Trump Imposes Up to 100% Tariffs on Certain Brand-Name Drug Imports in National Security Move

President Donald Trump announced plans to impose tariffs of up to 100% on certain brand-name imported patented pharmaceuticals and related ingredients, labeling it as a national security measure in an effort dubbed 'America First'. The move aims to protect American pharmaceutical companies from foreign competition. The tariffs could affect various medications, including insulin and some heart conditions treatments. Trump's administration claims the policy will help preserve America's medical supply chain.